Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
34%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
25%
ALSO IN PPH
PPH
27
HOLDINGS
50%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
| MERCK & CO. INC. | 7.4% | 8.0% | 7.4% | |
| PFIZER INC | 6.6% | 4.7% | 4.7% | |
| JOHNSON & JOHNSON | 7.1% | 4.6% | 4.6% | |
| BRISTOL-MYERS SQUIBB CO | 6.9% | 4.4% | 4.4% | |
| ELI LILLY & CO | 4.3% | 23.8% | 4.3% | |
FTXH Overweight Relative to PPH
| BIOGEN IDEC INC | 4.2% | |
| CARDINAL HEALTH INC | 4.2% | |
| REGENERON PHARMACEUTICALS | 3.9% | |
| VERTEX PHARMACEUTICALS INC | 3.6% | |
| AMGEN INC | 3.6% | |
| UNITED THERAPEUTICS CORP | 3.4% | |
| GILEAD SCIENCES INC | 3.3% | |
| VIATRIS, INC. | 2.6% | |
| JOHNSON & JOHNSON | 2.5% | |
| BRISTOL-MYERS SQUIBB CO | 2.5% |
FTXH Underweight Relative to PPH
| ELI LILLY & CO | -19.5% | |
| NOVARTIS AG-ADR | -9.1% | |
| NOVO-NORDISK A/S-SPONS ADR | -6.0% | |
| GLAXOSMITHKLINE PLC-SPON ADR | -4.8% | |
| MCKESSON CORP | -4.6% | |
| ASTRAZENECA PLC-SPONS ADR | -4.5% | |
| SANOFI-AVENTIS-ADR | -4.2% | |
| CENCORA INC | -3.6% | |
| TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.3% | |
| TEVA PHARMACEUTICAL-SP ADR | -2.3% |